Inositol-1-phosphate synthetase mRNA as a new target for antisense inhibition of Mycobacterium tuberculosis

Journal of Biotechnology

Volumn 128, Issue 4, 2007, Pages 726-734

  Li, Yuanyuan ^a   Chen, Zhifei ^b   Li, Xiaobo ^a   Zhang, Hongling ^a   Huang, Qiang ^a   Zhang, Ying ^c   Xu, Shunqing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Tuberculosis Hospital   (China)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antisense oligonucleotides; Drug resistance; Inositol; Mycobacterium tuberculosis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDES; DRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS;

ADDITION REACTIONS; ANTIBIOTICS; BACTERIA; BIOSYNTHESIS; DRUG PRODUCTS; ENZYMES; PHOSPHATES;

RNA;

ANTISENSE OLIGODEOXYNUCLEOTIDE; INOSITOL; MESSENGER RNA; MYCOTHIOL; MYOINOSITOL 1 PHOSPHATE SYNTHASE; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOROTHIOIC ACID; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; TOXIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CYSTEINE; GLYCOPEPTIDES; HYDROGEN PEROXIDE; INOSITOL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; OLIGONUCLEOTIDES, ANTISENSE; OXIDANTS; RNA, MESSENGER; THIONUCLEOTIDES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33847356371     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.12.019     Document Type: Article

References (30)

1. Aboul-Fadl T. Antisense oligonucleotides: the state of the art. Curr. Med. Chem. 12 19 (2005) 2193-2214
2. Agrawal S., and Zhang R. Pharmacokinetics of oligonucleotides. Ciba Found. Symp. 209 (1997) 60-75 discussion 75-8
3. Agrawal S., and Zhao Q. Antisense therapeutics. Curr. Opin. Chem. Biol. 2 4 (1998) 519-528
4. Anderberg S.J., Newton G.L., and Fahey R.C. Mycothiol biosynthesis and metabolism. Cellular levels of potential intermediates in the biosynthesis and degradation of mycothiol in mycobacterium smegmatis. J. Biol. Chem. 273 46 (1998) 30391-30397
5. Andratschke N., Grosu A.L., Molls M., and Nieder C. Perspectives in the treatment of malignant gliomas in adults. Anticancer Res. 21 5 (2001) 3541-3550
6. Aoyama T., Zhao W., Kojima F., Muraoka Y., Naganawa H., Takeuchi T., and Aoyagi T. Cysfluoretin, a new inhibitor of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. J. Antibiot. (Tokyo) 46 9 (1993) 1471-1474
7. Arca P., Hardisson C., and Suarez J.E. Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria. Antimicrob. Agents Chemother. 34 5 (1990) 844-848
8. Barker Jr. R.H., Metelev V., Rapaport E., and Zamecnik P. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 93 1 (1996) 514-518
9. Fahey R.C. Novel thiols of prokaryotes. Annu. Rev. Microbiol. 55 (2001) 333-356
10. Fahey R.C., and Newton G.L. Determination of low-molecular-weight thiols using monobromobimane fluorescent labeling and high-performance liquid chromatography. Meth. Enzymol. 143 (1987) 85-96
11. Harth G., Horwitz M.A., Tabatadze D., and Zamecnik P.C. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. Proc. Natl. Acad. Sci. U.S.A. 99 24 (2002) 15614-15619
12. Harth G., Zamecnik P.C., Tang J.Y., Tabatadze D., and Horwitz M.A. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-l-glutamate/glutamine cell wall structure, and bacterial replication. Proc. Natl. Acad. Sci. U.S.A. 97 1 (2000) 418-423
13. Hayward D., Wiid I., and van Helden P. Differential expression of mycothiol pathway genes: are they affected by antituberculosis drugs?. IUBMB Life 56 3 (2004) 131-138
14. Kozloff L.M., Turner M.A., Arellano F., and Lute M. Phosphatidylinositol, a phospholipid of ice-nucleating bacteria. J. Bacteriol. 173 6 (1991) 2053-2060
15. Lisziewicz J., Sun D., Klotman M., Agrawal S., Zamecnik P., and Gallo R. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. Proc. Natl. Acad. Sci. U.S.A. 89 23 (1992) 11209-11213
16. Mathews D.H.D., Childs J.L., Schroeder S.J., Zuker M., and Turner D.H. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 7287-7292
17. Milner N., Mir K.U., and Southern E.M. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat. Biotechnol. 15 6 (1997) 537-541
18. Movahedzadeh F., Smith D.A., Norman R.A., Dinadayala P., Murray-Rust J., Russell D.G., Kendall S.L., Rison S.C., McAlister M.S., Bancroft G.J., et al. The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence. Mol. Microbiol. 51 4 (2004) 1003-1014
19. Newton G.L., Av-Gay Y., and Fahey R.C. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry 39 35 (2000) 10739-10746
20. Newton G.L., Unson M.D., Anderberg S.J., Aguilera J.A., Oh N.N., delCardayre S.B., Av-Gay Y., and Fahey R.C. Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis. Biochem. Biophys. Res. Commun. 255 2 (1999) 239-244
21. Patzel V., Steidl U., Kronenwett R., Haas R., and Sczakiel G. A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res. 27 22 (1999) 4328-4334
22. Patzel V., zu Putlitz J., Wieland S., Blum H.E., and Sczakiel G. Theoretical and experimental selection parameters for HBV-directed antisense RNA are related to increased RNA-RNA annealing. Biol. Chem. 378 6 (1997) 539-543
23. Pittner F., Tovarova I.I., Kornitskaya E.Y., Khokhlov A.S., and Hoffmann-Ostenhof O. Myo-inositol-1-phosphate synthase from Streptomyces griseus (studies on the biosynthesis of cyclitols, XXXVIII). Mol. Cell. Biochem. 25 1 (1979) 43-46
24. Rastogi N., Frehel C., Ryter A., Ohayon H., Lesourd M., and David H.L. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?. Antimicrob. Agents Chemother. 20 5 (1981) 666-677
25. Rastogi N., Goh K.S., and David H.L. Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein-Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method. Res. Microbiol. 140 6 (1989) 405-417
26. Rastogi N., Goh K.S., and David H.L. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agents Chemother. 34 5 (1990) 759-764
27. Rawat M., Newton G.L., Ko M., Martinez G.J., Fahey R.C., and Av-Gay Y. Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics. Antimicrob. Agents Chemother. 46 11 (2002) 3348-3355
28. WHO, 2006. The WHO Global Tuberculosis Program. http://www.who.int/tb/en/.
29. Zhang Y. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 529-564
30. Zhao Q., Zhou R., Temsamani J., Zhang Z., Roskey A., and Agrawal S. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice. Antisense Nucleic Acid Drug Dev. 8 6 (1998) 451-458